News

Humanetics Corporation (Humanetics) announced that it has received funding from the U.S. Department of Defense to conduct a series of studies with its new drug candidate, BIO 300. BIO…
Read More...

Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced the signing of a strategic collaboration and…
Read More...

Moderna Inc. announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of…
Read More...

BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC ("Hong…
Read More...

Eli Lilly and Company  announced the successful completion of its acquisition of Prevail Therapeutics Inc. The acquisition establishes a new modality for drug discovery and development…
Read More...

Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMER™ biologics, announces a significant breakthrough in the identification of…
Read More...

Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, announced the initiation of a two-part, four-arm, human safety and efficacy trial…
Read More...

Servier, a global and independent pharmaceutical Group, and MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced a research partnership to identify and develop small…
Read More...

Mitsubishi Tanabe Pharma America, Inc. and Aquestive Therapeutics, Inc. announced a licensing and supply deal for the U.S. rights to commercialize EXSERVAN (riluzole), an oral film…
Read More...

Akron Biotechnology, LLC (Akron Biotech), announced it has signed an exclusive global agreement to manufacture virally inactivated Human AB Serum for the cell therapy market using…
Read More...

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and…
Read More...

T-Cure Bioscience, Inc., a privately held clinical-stage immuno-oncology company developing the next generation of T cell receptor (TCR) therapies for patients with solid tumors, and…
Read More...

Gritstone Oncology, Inc. a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, announced that it is advancing…
Read More...

Cocrystal Pharma, Inc. a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses,…
Read More...

Thermo Fisher Scientific Inc. announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450…
Read More...

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company and Merus N.V. a clinical-stage oncology company developing multi-specific antibodies, today announced…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune…
Read More...

TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases…
Read More...

Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELP platform to develop…
Read More...

Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, and Lonza announced their agreement in support of ARU-1801, Aruvant's one-time…
Read More...